Augmented reality versus standard tests to assess cognition and function in early Alzheimer’s disease

Augmented reality versus standard tests to assess cognition and function in early Alzheimer’s disease

Abstract Augmented reality (AR) apps, in which the virtual and real world are combined, can recreate instrumental activities of daily living (IADL) and are therefore promising to measure cognition needed for IADL in early Alzheimer’s disease (AD) both in the clinic and in the home settings. The prim...

Full description

Bibliographic Details
Main Authors: Marijn Muurling, Casper de Boer, Srinivasan Vairavan, Robbert L. Harms, Antonella Santuccione Chadha, Ioannis Tarnanas, Estefania Vilarino Luis, Dorota Religa, Martha Therese Gjestsen, Samantha Galluzzi, Marta Ibarria Sala, Ivan Koychev, Lucrezia Hausner, Mara Gkioka, Dag Aarsland, Pieter Jelle Visser, Anna-Katharine Brem
Format: Article
Language:English
Published: Nature Portfolio 2023-12-01
Series:npj Digital Medicine
Online Access:https://doi.org/10.1038/s41746-023-00978-6

Internet

https://doi.org/10.1038/s41746-023-00978-6

Similar Items